![gld lam pclp gld lam pclp](https://www.leuchtenking.de/produktbilder/320x300/uni-elektro_ledpclp40d_5w827_230vglfr_e27_10x1_osram_parathom_classic_tropfenlampe_e27_p_5w_827_matt_-_dimmbar_-_warmweiss710506980.jpg)
7 Of note, sales of the HPU-20 in the United States were discontinued in 2011, and the manufacturer has communicated its intention to discontinue sales of the compatible probes in 2019 (personal communication). 3 A power setting of 25 J to 30 J per pulse, using 4 to 5 pulses (total of 100-150 J) per station (before the probe position is changed) has been recommended for peptic ulcer bleeding. Once the pulse has been initiated, the duration of activation is predetermined and will deliver the entire amount of preselected energy. A foot pedal controls heat activation and irrigation. 7 The probe is placed directly at the site of the bleeding vessel, either perpendicularly or tangentially, with pressure applied for coaptive coagulation. The PTFE coating reduces adherence of the probe to tissue. The probe transfers heat from its end or sides, causing tissue coagulation. 3 The probes are reusable and are compatible with the HPU-20 (Olympus America, Center Valley, Pa, USA) power source. The heater probe comprises a PTFE-coated hollow aluminum cylinder with an inner heating coil and an irrigation port at the tip of a 230- to 300-cm 7F to 10F catheter. Standard: opening width 8 mm, angled tip designįujifilm Medical Systems (Wayne, NJ, USA).Short: opening width 6 mm, angled tip design.JR: opening width 4.5 mm scissor-like jaw.Bipolar coagulation provides coagulation at any angle.Bicap superconductor, multielectrode bipolar probe.FlexiTip disposable sclerotherapy needle - optic yellow tip.FlexiTip disposable sclerotherapy needle - standard.Medtronic Endoscopic Technologies (Chelmsford, Mass, USA) Technology Status Evaluation Reports are not rules and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment or payment for such treatment. Technology Status Evaluation Reports are scientific reviews provided solely for educational and informational purposes. For this review, the MEDLINE database was searched through September 2017 for articles related to endoscopic hemostasis devices by using relevant keywords such as “gastrointestinal bleeding,” “GI bleeding,” “nonvariceal bleeding,” “endoscopic hemostasis,” and “endoscopic treatment,” among others. When financial guidance is indicated, the most recent coding data and list prices at the time of publication are provided. Technology Status Evaluation Reports are drafted by 1 or 2 members of the ASGE Technology Committee, reviewed and edited by the committee as a whole, and approved by the Governing Board of the ASGE. Technical data are gathered from traditional and Web-based publications, proprietary publications, and informal communications with pertinent vendors. In such cases, large case series, preliminary clinical studies, and expert opinions are used. Controlled clinical trials are emphasized, but in many cases, data from randomized controlled trials (RCTs) are lacking. Both are supplemented by accessing the “related articles” feature of PubMed and by scrutinizing pertinent references cited by the identified studies. Food and Drug Administration Center for Devices and Radiological Health) database search to identify the reported adverse events of a given technology. Evidence-based methodology is used, with a MEDLINE literature search to identify pertinent clinical studies on the topic and a MAUDE (U.S. The American Society for Gastrointestinal Endoscopy (ASGE) Technology Committee provides reviews of existing, new, or emerging endoscopic technologies that have an impact on the practice of GI endoscopy.